星空体育官方入口网站网址大全-登录入口官网

#野生型#

48篇内容 | 1332人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2082921, encodeId=f85d208292171, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Clin Cancer Res：III期临床研究CATNON表明IDH野生型的胶质母细胞瘤中，在放疗的基础上加用替莫唑胺并不能改善患者的预后, objectType=article, longId=300739, objectId=32fb300e39e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32fb300e39e8, replyNumber=0, likeNumber=66, createdTime=2022-08-05, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32fb300e39e8, moduleTitle=Clin Cancer Res：III期临床研究CATNON表明IDH野生型的胶质母细胞瘤中，在放疗的基础上加用替莫唑胺并不能改善患者的预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=32fb300e39e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082919, encodeId=2246208291988, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Oncologist：RAS/BRAF野生型转移性结直肠癌(mCRC)患者中以抗EGFR为基础的再诱导治疗的疗效, objectType=article, longId=299377, objectId=94492993e786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94492993e786, replyNumber=0, likeNumber=0, createdTime=2022-05-12, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94492993e786, moduleTitle=Oncologist：RAS/BRAF野生型转移性结直肠癌(mCRC)患者中以抗EGFR为基础的再诱导治疗的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=94492993e786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082915, encodeId=b4bb20829152b, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Cancers：皮肤毒性(ST) 预测RAS野生型转移性结直肠癌西妥昔单抗联合avelumab再挑战治疗的疗效, objectType=article, longId=220587, objectId=fda922058e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fda922058e46, replyNumber=0, likeNumber=43, createdTime=2022-09-27, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fda922058e46, moduleTitle=Cancers：皮肤毒性(ST) 预测RAS野生型转移性结直肠癌西妥昔单抗联合avelumab再挑战治疗的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fda922058e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082916, encodeId=981a2082916b7, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察, objectType=article, longId=220892, objectId=769f22089252, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769f22089252, replyNumber=0, likeNumber=60, createdTime=2022-10-16, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769f22089252, moduleTitle=西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=769f22089252)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082918, encodeId=34db20829187a, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, objectType=article, longId=221344, objectId=e1b922134447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b922134447, replyNumber=0, likeNumber=51, createdTime=2022-06-28, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b922134447, moduleTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e1b922134447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082912, encodeId=d3fa208291277, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Lancet：EGFR野生型的早期NSCLC患者，免疫治疗获益显著（IMpower010研究）, objectType=article, longId=217564, objectId=4a9821e5642b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a9821e5642b, replyNumber=0, likeNumber=72, createdTime=2021-10-26, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a9821e5642b, moduleTitle=Lancet：EGFR野生型的早期NSCLC患者，免疫治疗获益显著（IMpower010研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a9821e5642b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082924, encodeId=df8c2082924a3, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效, objectType=article, longId=729659, objectId=add1e2965928, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=add1e2965928, replyNumber=0, likeNumber=54, createdTime=2023-05-03, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=add1e2965928, moduleTitle=J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=add1e2965928)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082917, encodeId=9d41208291eba, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Eur J Cancer：Rucaparib治疗BRCA1/2野生型转移性乳腺癌的疗效, objectType=article, longId=221327, objectId=bdda22132edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdda22132edc, replyNumber=0, likeNumber=60, createdTime=2022-07-27, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdda22132edc, moduleTitle=Eur J Cancer：Rucaparib治疗BRCA1/2野生型转移性乳腺癌的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bdda22132edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082923, encodeId=6d6f2082923f1, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=J Clin Oncol：mFOLFOXIRI方案联合帕尼单抗治疗RAS/BRAF野生型转移性结直肠癌, objectType=article, longId=729558, objectId=3e05e29558cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e05e29558cc, replyNumber=0, likeNumber=78, createdTime=2022-09-08, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e05e29558cc, moduleTitle=J Clin Oncol：mFOLFOXIRI方案联合帕尼单抗治疗RAS/BRAF野生型转移性结直肠癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3e05e29558cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082920, encodeId=c5132082920a7, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后, objectType=article, longId=299670, objectId=2fd12996e0f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd12996e0f7, replyNumber=0, likeNumber=70, createdTime=2023-01-14, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd12996e0f7, moduleTitle=JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2fd12996e0f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082922, encodeId=ccdd2082922f0, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Clin Cancer Res：替莫唑胺联合放疗 vs 单放疗在IDH野生型胶质母细胞瘤中的疗效, objectType=article, longId=300901, objectId=48f130090136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48f130090136, replyNumber=0, likeNumber=69, createdTime=2022-09-15, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48f130090136, moduleTitle=Clin Cancer Res：替莫唑胺联合放疗 vs 单放疗在IDH野生型胶质母细胞瘤中的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=48f130090136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082913, encodeId=ce5d208291355, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, objectType=article, longId=219464, objectId=7756219464f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7756219464f4, replyNumber=0, likeNumber=67, createdTime=2022-04-14, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7756219464f4, moduleTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7756219464f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082914, encodeId=e305208291427, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, objectType=article, longId=219570, objectId=1d282195e0e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d282195e0e7, replyNumber=0, likeNumber=58, createdTime=2022-01-17, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d282195e0e7, moduleTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d282195e0e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082911, encodeId=0b6c208291111, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, objectType=article, longId=217301, objectId=986821e3019a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986821e3019a, replyNumber=0, likeNumber=73, createdTime=2022-08-08, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986821e3019a, moduleTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=986821e3019a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082910, encodeId=206b2082910c9, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Oncogene：雄激素受体以氧依赖性方式调控VHL野生型透明细胞肾细胞癌的转移途径, objectType=article, longId=201400, objectId=bb92201400a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb92201400a1, replyNumber=0, likeNumber=66, createdTime=2020-10-17, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb92201400a1, moduleTitle=Oncogene：雄激素受体以氧依赖性方式调控VHL野生型透明细胞肾细胞癌的转移途径, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bb92201400a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082909, encodeId=f66c2082909bd, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Radiology：DTI和PWI放射组学与高通量测序技术指导IDH野生型胶质母细胞瘤的预后, objectType=article, longId=192502, objectId=b21019250299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b21019250299, replyNumber=0, likeNumber=59, createdTime=2020-04-20, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b21019250299, moduleTitle=Radiology：DTI和PWI放射组学与高通量测序技术指导IDH野生型胶质母细胞瘤的预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b21019250299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082907, encodeId=d89e208290eb0, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, objectType=article, longId=179432, objectId=0a3e1e94321f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e1e94321f, replyNumber=0, likeNumber=80, createdTime=2020-07-14, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e1e94321f, moduleTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a3e1e94321f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082908, encodeId=8757208290859, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=NMPA批准默克的EGFR单抗西妥昔联合FOLFOX或FOLFIRI化疗，用于国内RAS野生型转移性结直肠癌患者的一线治疗, objectType=article, longId=180183, objectId=e8d718018362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d718018362, replyNumber=0, likeNumber=0, createdTime=2020-06-27, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d718018362, moduleTitle=NMPA批准默克的EGFR单抗西妥昔联合FOLFOX或FOLFIRI化疗，用于国内RAS野生型转移性结直肠癌患者的一线治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e8d718018362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082905, encodeId=56b820829051b, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4, objectType=article, longId=149868, objectId=57f314986823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f314986823, replyNumber=0, likeNumber=62, createdTime=2019-08-19, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f314986823, moduleTitle=J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57f314986823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082904, encodeId=66ae208290409, content=<a href='/topic/show?id=2436961068e' target=_blank style='color:#2F92EE;'>#野生型#</a>, objectTitle=JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌, objectType=article, longId=148749, objectId=88ec148e49bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ec148e49bc, replyNumber=0, likeNumber=56, createdTime=2019-03-21, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ec148e49bc, moduleTitle=JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88ec148e49bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

野生型

2020-05-29

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Clin Cancer Res：III期临床研究CATNON表明IDH野生型的胶质母细胞瘤中，在放疗的基础上加用替莫唑胺并不能改善患者的预后

2022-08-05

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Oncologist：RAS/BRAF野生型转移性结直肠癌(mCRC)患者中以抗EGFR为基础的再诱导治疗的疗效

2022-05-12

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Cancers：皮肤毒性(ST) 预测RAS野生型转移性结直肠癌西妥昔单抗联合avelumab再挑战治疗的疗效

2022-09-27

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察

2022-10-16

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期

2022-06-28

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Lancet：EGFR野生型的早期NSCLC患者，免疫治疗获益显著（IMpower010研究）

2021-10-26

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

J Clin Oncol：mFOLFOXIRI+帕尼单抗对比FOLFOX+帕尼单抗一线治疗RAS和BRAF野生型转移性结直肠癌(mCRC)的疗效

2023-05-03

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Eur J Cancer：Rucaparib治疗BRCA1/2野生型转移性乳腺癌的疗效

2022-07-27

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

J Clin Oncol：mFOLFOXIRI方案联合帕尼单抗治疗RAS/BRAF野生型转移性结直肠癌

2022-09-08

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

JNCCN:左侧RAS/RAF野生型(WT) 转移性结直肠癌（mCRC）患者治疗策略趋势和预后

2023-01-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Clin Cancer Res：替莫唑胺联合放疗 vs 单放疗在IDH野生型胶质母细胞瘤中的疗效

2022-09-15

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究

2022-04-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理

2022-01-17

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期

2022-08-08

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Oncogene：雄激素受体以氧依赖性方式调控VHL野生型透明细胞肾细胞癌的转移途径

2020-10-17

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Radiology：DTI和PWI放射组学与高通量测序技术指导IDH野生型胶质母细胞瘤的预后

2020-04-20

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变

2020-07-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

NMPA批准默克的EGFR单抗西妥昔联合FOLFOX或FOLFIRI化疗，用于国内RAS野生型转移性结直肠癌患者的一线治疗

2020-06-27

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4

2019-08-19

ms5106640509429053 (审核中...)

前往app查看评论内容

#野生型#

JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌

2019-03-21

科室
- - 订阅+
  - 更多科室
工具
服务